CV Transforum Fall’26 Housing Discount Ends Sept. 7. 
Despite advances in guideline-directed medical therapy, congestion from heart failure (HF) remains the principal precipitant of costly emergency department (ED) visits, readmissions and symptom burden. The upcoming Centers for Medicare & Medicaid Services (CMS) Ambulatory Specialty Model (ASM) for HF further raises the stakes, shifting accountability and financial risk to the ambulatory setting and making avoidable hospitalizations and emergency department visits a direct threat to program performance.
Drawing on real-world experience from two U.S. health systems, this roadmap provides a scalable framework for cardiovascular leaders seeking to implement home-based decongestion with FUROSCIX® (furosemide injection) safely, efficiently and in alignment with CMS ASM and value-based care.
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.
